Products Categories
CAS No.: | 220620-09-7 |
---|---|
Name: | Tigecycline |
Article Data: | 16 |
Molecular Structure: | |
Formula: | C29H39N5O8 |
Molecular Weight: | 585.657 |
Synonyms: | 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-;N-[(5aR,6aS,7S,9Z,10aS)-9-(amino-hydroxy-methylidene)-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-2-(tert-butylamino)acetamide;Tygacil (TN);Tygacil;(4S,4aS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; |
EINECS: | 685-736-6 |
Density: | 1.455 g/cm3 |
Melting Point: | 164-166°C |
Boiling Point: | 890.922 °C at 760 mmHg |
Flash Point: | 492.612 °C |
Appearance: | Powder |
Safety: | 24/25 |
PSA: | 205.76000 |
LogP: | 1.67740 |
Conditions | Yield |
---|---|
With sodium iodide In N,N-dimethyl acetamide at 50℃; for 2h; | 92% |
Stage #1: 9-chloroacetamidominocycline; tert-butylamine With sodium iodide at 20℃; Stage #2: In water pH=5 - ~ 7.2; Product distribution / selectivity; | 50% |
With sodium iodide at 25 - 40℃; for 6h; Product distribution / selectivity; |
tigecycline
Conditions | Yield |
---|---|
In water at 0 - 5℃; for 2h; | 90% |
tigecycline
Conditions | Yield |
---|---|
Stage #1: 2-tert-butylaminoacetylchloride hydrochloride; <4S-(4α,12aα)>-9-amino-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride In water at 0 - 6℃; for 1h; Industry scale; Stage #2: With hydrogenchloride; ammonia In methanol; dichloromethane; water at 0 - 25℃; pH=0.42 - 7.4; Product distribution / selectivity; | 77% |
Stage #1: 2-tert-butylaminoacetylchloride hydrochloride; <4S-(4α,12aα)>-9-amino-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride In water at 0 - 6℃; for 1h; Industry scale; Stage #2: With hydrogenchloride; ammonia In methanol; dichloromethane; water at 0 - 25℃; pH=0.42 - 7.4; Product distribution / selectivity; | 77% |
Stage #1: 2-tert-butylaminoacetylchloride hydrochloride; <4S-(4α,12aα)>-9-amino-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride In water at 0 - 6℃; for 1h; Industry scale; Stage #2: With hydrogenchloride; ammonia In methanol; dichloromethane; water at 0 - 25℃; pH=0.42 - 7.4; Product distribution / selectivity; | 77% |
[4S-(4aα,12aα)]-9-amino-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
tigecycline
Conditions | Yield |
---|---|
Stage #1: 2-tert-butylaminoacetylchloride hydrochloride; [4S-(4aα,12aα)]-9-amino-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide In water at 0 - 5℃; for 0.666667 - 1h; Stage #2: With ammonia In water at 0 - 5℃; pH=7.2; Product distribution / selectivity; | 76.8% |
Stage #1: 2-tert-butylaminoacetylchloride hydrochloride; [4S-(4aα,12aα)]-9-amino-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide In water at 0 - 5℃; for 0.666667 - 1h; Stage #2: With ammonia In methanol; dichloromethane; water at 0 - 5℃; for 0.25h; pH=7.2; Product distribution / selectivity; | 76.8% |
Stage #1: 2-tert-butylaminoacetylchloride hydrochloride; [4S-(4aα,12aα)]-9-amino-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide In water at 0 - 5℃; for 0.666667 - 1h; Stage #2: With ammonia In methanol; dichloromethane; water at 0 - 5℃; for 0.25h; pH=7.2; Product distribution / selectivity; | 76.8% |
Conditions | Yield |
---|---|
Stage #1: 9-chloroacetamidominocycline hydrochloride; tert-butylamine With sodium iodide at 20℃; Stage #2: In water pH=5 - ~ 7.2; Product distribution / selectivity; | 35% |
3,3-dimethylbutanoic acid chloride
[4S-(4aα,12aα)]-9-amino-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
tigecycline
Conditions | Yield |
---|---|
With sodium iodide at 33 - 38℃; for 4h; Product distribution / selectivity; |
[4S-(4aα,12aα)]-9-amino-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
B
tigecycline
Conditions | Yield |
---|---|
Stage #1: 2-tert-butylaminoacetylchloride hydrochloride; [4S-(4aα,12aα)]-9-amino-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide In water at 0 - 5℃; for 0.666667 - 1h; Stage #2: With ammonia In water at 0 - 5℃; pH=7.2; Product distribution / selectivity; | |
Stage #1: 2-tert-butylaminoacetylchloride hydrochloride; [4S-(4aα,12aα)]-9-amino-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide In dichloromethane at 10 - 15℃; for 2h; Stage #2: With ammonia In methanol; dichloromethane; water at 5 - 8℃; pH=7.2; Product distribution / selectivity; | |
Stage #1: 2-tert-butylaminoacetylchloride hydrochloride; [4S-(4aα,12aα)]-9-amino-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide In N,N-dimethyl-formamide at 10 - 15℃; for 2h; Stage #2: With ammonia In methanol; water; N,N-dimethyl-formamide at 5 - 8℃; pH=7.2; Product distribution / selectivity; |
B
tigecycline
Conditions | Yield |
---|---|
Stage #1: 2-tert-butylaminoacetylchloride hydrochloride; <4S-(4α,12aα)>-9-amino-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride In water at 0 - 6℃; for 1 - 3h; Stage #2: With ammonia In water at 0 - 10℃; pH=7.2; Product distribution / selectivity; |
tigecycline
Conditions | Yield |
---|---|
Stage #1: <4S-(4α,12aα)>-9-amino-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide disulfate With sodium carbonate In water at 0℃; pH=2 - 3; Inert atmosphere; Stage #2: 2-tert-butylaminoacetylchloride hydrochloride With sodium carbonate In water at 0 - 30℃; pH=6.7; Inert atmosphere; |
1. Introduction of Tigecycline
Tigecycline, with its CAS NO.220620-09-7, is a kind of orange Powder. Its Synonyms are 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)- ; Tygacil ; (4S,4aS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide . Tigecycline is bacteriostatic and is a protein synthesis inhibitor by binding to the 30S ribosomal subunit of bacteria and thereby blocking entry of Aminoacyl-tRNA into the A site of the ribosome during prokaryotic translation.
2. Properties of Tigecycline
(1) XLogP3: -0.2 (2) H-Bond Donor: 7 (3) H-Bond Acceptor: 12
(4) Surface Tension: 80.036 dyne/cm (5) Density: 1.455 g/cm3 (6) Flash Point: 492.612 °C
(7) Enthalpy of Vaporization: 135.666 kJ/mol (8) Boiling Point: 890.922 °C at 760 mmHg
3. Structure descriptors of Tigecycline
IUPAC Name: (4S,4aS,5aR,12aR)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,
6-tetrahydro-4H-tetracene-2-carboxamide
InChI: InChI=1S/C29H39N5O8/c1-28(2,3)31-11-17(35)32-15-10-16(33(4)5)13-8-12-9-14-21(34(6)7)24(38)20(27(30)41)26(40)29(14,42)25(39)18(12)23(37)19(13)22(15)36/h10,12,14,21,31,36-37,40,42H,8-9,11H2,1-7H3,(H2,30,41)(H,32,35)/t12-,14-,21-,29-/m0/s1
InChIKey: SOVUOXKZCCAWOJ-HJYUBDRYSA-N
Canonical SMILES : CC(C)(C)NCC(=O)NC1=C(C2=C(CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C2O)O)O)C(=O)N)N(C)C)C(=C1)N(C)C)OIsomeric SMILES: CC(C)(C)NCC(=O)NC1=C(C2=C(C[C@H]3C[C@H]4[C@@H](C(=O)C(=C([C@]4(C(=O)C3=
C2O)O)O)C(=O)N)N(C)C)C(=C1)N(C)C)O
4. Uses of Tigecycline
Tigecycline is active against many bacteria including Gram-positive bacteria, Gram-negative bacteria and anaerobes ,it also has activity against methicillin-resistant Staphylococcus aureus (MRSA) and multi-drug resistant strains of Acinetobacter baumannii. It may have no activity against Pseudomonas spp. or Proteus spp. The drug is licenced for the treatment of skin,soft tissue infections ,and intra-abdominal infections.